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 3 
Abstract 35 
 36 
The C-type lectin receptor/Syk adaptor CARD9 facilitates protective antifungal immunity within 37 
the central nervous system (CNS), as human CARD9-deficiency causes fungal-specific CNS-38 
targeted infection susceptibility. CARD9 is required for neutrophil recruitment to the fungal-39 
infected CNS, which mediates fungal clearance. Here, we investigated host and pathogen 40 
factors that promote protective neutrophil recruitment during Candida albicans CNS invasion. 41 
IL-1 was essential for CNS antifungal immunity by driving CXCL1 production, which recruited 42 
CXCR2-expressing neutrophils. Neutrophil-recruiting IL-1 and CXCL1 production was 43 
induced in microglia by the fungal-secreted toxin Candidalysin, in a p38-cFos-dependent 44 
manner. Importantly, microglia relied on CARD9 for production of IL-1 via both Il1b 45 
transcriptional regulation and inflammasome activation, and of CXCL1 in the fungal-infected 46 
CNS. Microglia-specific Card9 deletion impaired IL-1and CXCL1 production and neutrophil 47 
recruitment, and increased CNS fungal proliferation. Taken together, an intricate network of 48 
host-pathogen interactions promotes CNS antifungal immunity, which is impaired in human 49 
CARD9-deficiency leading to CNS fungal disease.    50 
 4 
Introduction 51 
 52 
The CNS is invaded by microorganisms during systemic infections, yet the mechanisms of 53 
CNS-specific anti-microbial immunity remain poorly-understood. This is particularly true for 54 
CNS fungal infections, which present unmet diagnostic and treatment challenges, leading to 55 
unacceptably high mortality (>50%)1. Fungal CNS invasion is enhanced by fungal-specific risk 56 
factors, including HIV infection, neutropenia, corticosteroid use, and Bruton’s tyrosine kinase 57 
inhibition1. However, the most striking human risk factor for selective CNS fungal infection 58 
susceptibility is inherited deficiency of the C-type lectin receptor (CLR)–Syk adaptor CARD9.  59 
 60 
CARD9 relays fungal-sensing signals downstream of the CLR superfamily of pattern 61 
recognition receptors, including Dectin-1, Dectin-2, Dectin-3 and Mincle. Syk kinase is 62 
recruited to phosphorylated ITAM sequences of CLRs or their signaling partner FcR to form 63 
the CARD9-BCL10-MALT1 signalosome, which activates downstream effectors including 64 
NFB, NLRP3 inflammasome and MAPK signaling. 65 
 66 
CARD9-deficient patients manifest fungal-specific infection susceptibility, predominantly in the 67 
CNS by Candida albicans2, 3, 4. We previously showed that CARD9-deficiency in humans and 68 
mice confers a fungal- and brain-specific defect in neutrophil recruitment, which is detrimental 69 
for control of CNS fungal invasion5. However, the CNS cellular and molecular cues that 70 
promote protective neutrophil recruitment during C. albicans invasion and their dependence on 71 
CARD9 in vivo remain unknown. 72 
 73 
 5 
Herein, we systematically investigated host and pathogen factors that promote protective 74 
neutrophil influx into the C. albicans-infected CNS to better understand the pathogenesis of 75 
human CARD9-deficiency. We uncover an intricate pathway by which the C. albicans-secreted 76 
toxin Candidalysin engages microglia to produce IL-1 and CXCL1 for protective recruitment of 77 
CXCR2-expressing neutrophils. Importantly, microglial IL-1 and CXCL1 production depends 78 
on CARD9 and specific deletion of microglial CARD9 impairs neutrophil recruitment to the C. 79 
albicans-infected CNS. Collectively, our data unveil complex host-pathogen interactions that 80 
recruit protective neutrophils during fungal CNS invasion and reveal the mechanism that 81 
underlies CNS fungal susceptibility in CARD9-deficiency.  82 
 6 
Results 83 
 84 
CLR Functional Redundancy during Fungal CNS Invasion 85 
As previously shown, CARD9 is essential for protective CNS immunity against C. albicans, 86 
principally through promoting early neutrophil recruitment (Fig. 1a). We first investigated the 87 
relative contribution of CARD9-coupled CLRs, which are expressed by brain-resident microglia 88 
(Supplementary Fig. 1), in mediating this protective neutrophil recruitment. We infected mice 89 
deficient in Dectin-1 (Clec7a–/–), Dectin-2 (Clec4n–/–), Dectin-3 (Clec4d–/–) and Mincle (Clec4e–/–) 90 
and measured brain neutrophil accumulation at 24 h post-infection (Supplementary Fig. 2). 91 
We chose this time-point since it is the peak of the neutrophil response in wild-type animals 92 
and neutrophil depletion at this time-point increases susceptibility to brain fungal invasion5. 93 
 94 
Animals individually deficient in CARD9-coupled CLRs recruited neutrophils to the infected 95 
brain normally (Fig. 1b). Despite this, we observed increases in fungal brain burdens at 72 h 96 
post-infection in mice deficient in Dectin-1 or Dectin-2 but not Dectin-3 or Mincle (Fig. 1c), 97 
suggesting that Dectin-1 and Dectin-2 employ neutrophil recruitment-independent mechanisms 98 
to protect against brain fungal proliferation. Indeed, brain-infiltrating neutrophils from Dectin-1 99 
and Dectin-2-deficient animals exhibited reduced fungal phagocytosis (Supplementary Fig. 100 
3), consistent with prior findings6.  101 
 102 
To activate CARD9-dependent signaling, phosphorylation occurs on the ITAM sequence within 103 
the intracellular tail of Dectin-1 or FcR, which Dectin-2, Dectin-3 and Mincle associate with. 104 
Therefore, we assessed whether deletion of all four CLRs affected the neutrophil response in 105 
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the infected brain. We used mice doubly-deficient in Dectin-1 and FcRClec7a–/–Fcerg1–/–) 106 
and found that loss of both Dectin-1 and the FcR-coupled CLRs phenocopied Card9-107 
deficiency with significantly decreased neutrophil recruitment and corresponding increased 108 
brain fungal burdens (Fig. 1b,c). Taken together, CARD9-coupled CLRs functionally 109 
compensate to mediate neutrophil recruitment-dependent protection against C. albicans CNS 110 
invasion. 111 
 112 
MALT1 is Required for Defense against CNS Candidiasis  113 
The CARD9-MALT1-BCL10 signalosome is necessary for transducing fungal-sensing 114 
intracellular signals. Human deficiencies of MALT1 or BCL10 cause defective innate and 115 
adaptive immune responses, and many of these patients die in childhood from bacterial and 116 
viral infections2. Human MALT1-deficiency additionally manifests with mucosal candidiasis, 117 
suggesting that antifungal immunity is impaired in these patients. However, whether MALT1-118 
deficiency also predisposes to brain-targeted candidiasis is unknown. To test this, we infected 119 
Malt1-deficient mice and assessed control of CNS C. albicans growth. Malt1–/– animals 120 
recruited neutrophils to the brain similarly to wild-type, however these animals exhibited 121 
uncontrolled brain fungal growth at 72 h post-infection (Fig. 1d). Therefore, MALT1 is critical 122 
for protective CNS immunity against C. albicans; however, the MALT1-dependent protective 123 
mechanisms operating in this tissue are independent of neutrophil recruitment, unlike CARD9.  124 
 125 
Candida Drives CNS Neutrophil Influx via IL-1 and CXCL1 126 
To determine the local cues that recruit protective neutrophils in the infected CNS, we 127 
examined key cytokine and chemokine circuits using gene-deficient mice. We began by 128 
 8 
infecting IL-1 receptor (IL-1R)-deficient mice, because production of IL-1 by human peripheral 129 
blood mononuclear cells upon fungal stimulation depends on CARD95, 7, and because IL-1R 130 
was previously shown to promote neutrophil recruitment to fungal-infected mucosal tissues8, 9, 131 
and to the bacterial-infected brain10. Upon C. albicans challenge, IL-1R-deficient mice 132 
phenocopied Card9-deficient mice, with a loss of early brain neutrophil recruitment and 133 
accompanying increased fungal brain burdens (Fig. 2a,b). Consistent with this, loss of the IL-134 
1R signaling adaptor MyD88 caused similar defects in recruiting neutrophils and controlling 135 
fungal proliferation in the infected brain (Fig. 2a,b). 136 
 137 
We next assessed which IL-1R ligands were important for driving CNS protection by infecting 138 
mice deficient in IL-1, IL-1 or both. Mice lacking IL-1 had a small reduction in neutrophil 139 
numbers and a slight increase in fungal brain burden at 24 h post-infection (Fig. 2a,b). 140 
However, the lack of IL-1 appeared to be compensated by IL-1, since Il1a–/– animals 141 
recovered and controlled fungal brain infection similar to wild-type by 72 h post-infection (Fig. 142 
2b). In keeping with the critical contribution of IL-1, mice deficient in IL-1, or both IL-1/IL-143 
1, exhibited significantly reduced neutrophil accumulation and were highly susceptible for 144 
fungal brain invasion (Fig. 2a,b). Therefore, IL-1 is a critical mediator of neutrophil 145 
recruitment to promote control of C. albicans brain infection. 146 
 147 
Downstream of IL-1R, the production of local chemotactic mediators recruits immune cells to 148 
infected tissues. Previously, we showed that the CNS-neutropenia observed in mouse and 149 
human CARD9-deficiency is not caused by neutrophil-intrinsic chemotaxis defects5, but rather 150 
by insufficient local production of soluble chemotactic mediators. However, which among the 151 
 9 
several chemoattractants and their receptors recruit(s) protective neutrophils to the C. 152 
albicans-infected CNS is unknown.  153 
 154 
CARD9 was shown to drive production of the CXCR2 ligands CXCL1 and CXCL2 during 155 
inflammatory arthritis11 and murine subcutaneous phaeohyphomycosis12. During systemic C. 156 
albicans infection, CCR1 drives renal neutrophil accumulation and immune-related kidney 157 
destruction13, the leukotriene B4 (LTB4) receptor LTB4R1 promotes detrimental pulmonary 158 
neutrophil accumulation14, and CXCR1 mediates neutrophil-dependent fungal killing in the 159 
kidney15. However, the role of these receptors in CNS anti-Candida immunity is unknown, 160 
while CXCR2 and fMet-Leu-Phe (fMLP) receptor FPR1 have not been examined in anti-161 
Candida defense. 162 
 163 
To test the relative dependence on these major neutrophil-targeted chemoattractant receptors 164 
in protecting the fungal-infected brain, we infected mice deficient in CCR1, CXCR1, CXCR2, 165 
LTB4R1 or FPR1 and measured neutrophil recruitment and fungal brain burdens. We found no 166 
involvement of the CCL3–CCR1, CXCL5–CXCR1, LTB4–LTB4R1 or fMLP–FPR1 axes in 167 
controlling fungal brain infection, in line with normal early neutrophil recruitment in infected 168 
Ccr1–/–, Cxcr1–/–, Ltb4r1–/– and Fpr1–/– animals (Fig. 2c,d and Supplementary Fig. 4). In 169 
contrast, CXCR2-deficient mice had significantly reduced neutrophil accumulation and 170 
corresponding significantly increased fungal brain growth (Fig. 2c,d). These data demonstrate 171 
the importance of the CXCR2 axis in neutrophil-mediated protection against C. albicans brain 172 
infection. 173 
 174 
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Next, we wondered which CXCR2 ligand may recruit protective neutrophils to the fungal-175 
infected brain. We infected Cxcl1–/– mice that lack expression of the potent neutrophil 176 
chemoattractant CXCL1. Notably, these animals had decreased neutrophil recruitment to the 177 
brain post-infection and exhibited a similar CNS invasion susceptibility phenotype to the Cxcr2–178 
/– mice (Fig. 2c,d). Therefore, the CXCL1/CXCR2 chemokine axis is critical for protection 179 
against C. albicans brain invasion by recruiting protective neutrophils. Importantly, this data 180 
indicates that the reduced CXCL1 in the human CARD9-deficient C. albicans-infected CSF is 181 
biologically relevant and significant5. 182 
 183 
IL-1Activates CXCL1 in the Fungal-Infected Brain 184 
Since both IL-1 and CXCL1 were required for protection, we investigated whether their 185 
activation in the infected brain was simultaneous or sequential. We measured IL-1 and 186 
CXCL1 in brain homogenates at 24 h post-infection in animals lacking these inflammatory 187 
mediators using ELISA. We found no defect in IL-1 levels in CXCL1-deficient infected brains; 188 
however, we discovered a significant defect in CXCL1 production in the absence of IL-1 (Fig. 189 
3a). To define the IL-1-dependent brain cellular sources of CXCL1, we infected wild-type and 190 
IL-1-deficient mice and used intracellular flow cytometry. CXCL1 and pro-IL-1 were 191 
produced by multiple myeloid phagocytes in the fungal-infected brain, including resident 192 
microglia, the most numerous immune cells in the brain, recruited Ly6Chi monocytes which 193 
have been implicated in controlling C. albicans CNS invasion16, and neutrophils themselves 194 
(Fig. 3b). Interestingly, Il1b–/– microglia recovered from C albicans-infected brains had a 195 
profound defect in CXCL1 production, exhibiting significant reductions under every ex vivo 196 
restimulation condition tested (Fig. 3c). Ly6Chi monocytes isolated from Il1b–/– C. albicans-197 
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infected brains produced less CXCL1 when restimulated ex vivo with LPS, with no differences 198 
detected under non-stimulated or zymosan-stimulated conditions. Neutrophil production of 199 
CXCL1 did not differ between the two mouse groups (Fig. 3c). Therefore, IL-1 is required for 200 
subsequent CXCL1 production from resident microglia and recruited monocytes, which in turn 201 
recruits CXCR2-expressing neutrophils to the fungal-infected brain (Fig. 2c). 202 
 203 
Candidalysin is a Fungal Avirulence Factor in the Brain 204 
Use of genetically-deficient mice allowed us to map the host pathway promoting protection 205 
against C. albicans brain infection, in which IL-1–IL-1R–MyD88 signaling activates CXCL1 206 
production by resident microglia and recruited monocytes to mobilize neutrophils into the CNS. 207 
To identify the pathogen-associated factors that induce this protective host pathway, we 208 
infected animals with C. albicans strains lacking known virulence factors and assessed 209 
neutrophil recruitment and IL-1 and CXCL1 production in the infected brain. 210 
 211 
C. albicans hyphae are the predominant CNS-invasive morphology of C. albicans5 and hyphal 212 
formation is associated with important virulence traits such as toxin and protease production, 213 
adhesion, invasion, and immune system activation17. Thus, we first asked whether neutrophil 214 
recruitment was impaired during infection with the hgc1/ C. albicans strain which cannot 215 
filament in vivo18. Indeed, infection with hypha-deficient hgc1/ C. albicans significantly 216 
impaired neutrophil recruitment and enhanced fungal CNS tissue invasion relative to the 217 
isogenic wild-type C. albicans strain (Fig. 4a). Thus, filamentation is strikingly not required for 218 
C. albicans invasion of brain tissue, in contrast to other organs such as the kidney18. 219 
 220 
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Candidalysin is a recently-described peptide toxin encoded by ECE1 and expressed 221 
exclusively by C. albicans hyphae19. Candidalysin was shown to mediate epithelial cell 222 
damage via pore formation in the plasma cell membrane resulting in IL-1 release and pro-223 
inflammatory cytokine production. Hence, Candidalysin-null mutants were highly attenuated in 224 
murine oropharyngeal and vulvovaginal candidiasis models19, 20, 21. Instead, we found that lack 225 
of Candidalysin promoted brain infection, and that this phenotype was specific to the 226 
Candidalysin peptide since mutant strains deficient in the entire gene (ece1/) or specifically 227 
in the Candidalysin-encoding portion of the gene (ece1/ + ECE1184-279) were both hyper-228 
virulent for C. albicans brain invasion (Fig. 4b).  229 
 230 
The increased ability of the Candidalysin-null mutants to proliferate within the brain directly 231 
correlated with the degree of neutrophil recruitment. We found a near absence of neutrophils in 232 
the brains of wild-type animals infected with Candidalysin-null strains and observed hyphal 233 
forms growing in the brain parenchyma with no neutrophilic reaction (Fig. 4c). In contrast, the 234 
Candidalysin-producing parental strain and the re-integrant control strain promoted neutrophil 235 
recruitment at 24 h post-infection, and these neutrophils clustered around invading hyphae 236 
(Fig. 4c). In line with the absence of neutrophils in the brains of mice infected with 237 
Candidalysin-null strains, IL-1 and CXCL1 were significantly reduced in brain homogenates 238 
from animals infected with these strains (Fig. 4d). Therefore, Candidalysin is a key fungal 239 
factor that activates the IL-1–CXCL1 protective pathway in vivo. Notably, in contrast to its role 240 
in the mucosa, Candidalysin acts as an avirulence factor in the brain by instigating protective 241 
host CNS immunity, underscoring the tissue-specific opposing roles that a microbial factor may 242 
play during infection with the same pathogen17. 243 
 13 
 244 
We next wondered whether other C. albicans hyphae-associated secreted proteins also 245 
activate protective neutrophil responses in the brain. Secreted aspartyl proteases (Saps) are 246 
enzymes with extracellular proteolytic activity and are linked to virulence22. C. albicans Saps 247 
promote neutrophil recruitment during vulvovaginal candidiasis in mice23, 24. Expression of the 248 
SAP4-6 subfamily is coordinately regulated with hyphal formation22, therefore we tested 249 
whether these hyphal-associated Saps contributed towards virulence during brain invasion. 250 
Wild-type animals infected with the triple-deficient strain sap4/5/6/ had comparable brain 251 
fungal burdens to animals infected with the complemented control strain (Fig. 4e). In line with 252 
this, we saw no difference in CNS neutrophil recruitment in these animals, indicating that C. 253 
albicans Saps exhibit tissue-specific roles in promoting neutrophil recruitment during 254 
infection23, 24 (Fig. 4e). Therefore, protective CNS neutrophil recruitment is activated by 255 
Candidalysin, and not by other C. albicans hyphae-secreted enzymes. 256 
 257 
Candidalysin Drives Microglial IL-1 and CXCL1 in vivo 258 
Since Candidalysin activates host CNS immunity, we sought to define the Candidalysin-259 
responsive CNS immune cells. We infected wild-type mice with either the parental strain of C. 260 
albicans (BWP17) or the Candidalysin-null strain (ece1/), and analyzed IL-1 and CXCL1 261 
production using intracellular flow cytometry at 24 h post-infection (Fig. 5).  262 
Although all brain phagocytes produced both IL-1 and CXCL1, microglia were the only 263 
population to exhibit dependence on Candidalysin, since microglia isolated from ece1/-264 
infected brains produced significantly less IL-1 and CXCL1 ex vivo (Fig. 5a,b). In contrast, 265 
Ly6Chi monocytes and neutrophils did not depend on Candidalysin for IL-1 and CXCL1 266 
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production, suggesting that other as-yet unidentified fungal factors activate this pathway in 267 
these phagocytes. Together, our data show that Candidalysin acts on microglia to stimulate IL-268 
1 release, which in turn drives CXCL1 production that is required for protective neutrophil 269 
CNS recruitment. 270 
 271 
Candidalysin Drives Differing Glial IL-1–CXCL1 ex vivo 272 
To gain mechanistic insights into how microglia respond to Candidalysin, we cultured the 273 
microglia cell line BV-225 in the presence of synthetic Candidalysin and measured IL-1 and 274 
CXCL1 in the supernatants by ELISA. In line with our in vivo work, we found time- and dose-275 
dependent IL-1 production by BV-2 cells in response to Candidalysin (Fig. 6a). However, we 276 
did not detect CXCL1 from BV-2 cells stimulated under these conditions. We first considered 277 
that this could be due to Candidalysin-induced damage that may prevent BV-2 cells from 278 
producing CXCL1 after IL-1 secretion. Indeed, as shown for epithelial cells19, Candidalysin 279 
mediated dose-dependent cell damage to BV-2 microglia (Fig. 6b). Alternatively, additional 280 
signals beyond IL-1 derived from non-microglial CNS cells, might be required for microglial 281 
CXCL1 induction, acting in trans. To test this hypothesis, we co-cultured BV-2 cells with 282 
immortalized C8-D1A astrocytes in the presence of Candidalysin and measured IL-1 and 283 
CXCL1 in the supernatants. We chose astrocytes since they are known to respond to IL-1 to 284 
produce inflammatory mediators, including CXCL1, in other models of CNS inflammation26, 27, 285 
28. We found that astrocytes responded to Candidalysin to produce CXCL1 (Fig. 6c), but not 286 
IL-1 (data not shown), and that CXCL1 production significantly increased when astrocytes 287 
and microglia were co-cultured (Fig. 6c). To confirm that microglia are a relevant cellular 288 
source of CXCL1 detected during microglia-astrocyte co-culture, we performed intracellular 289 
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staining for CXCL1 and found that BV-2 microglia are significant producers of CXCL1 in 290 
response to Candidalysin, but only when astrocytes were present (Fig. 6d). Therefore, 291 
astrocytes provide additional signals to microglia that are needed for CXCL1 production in 292 
response to Candidalysin.  293 
 294 
We next investigated the pathway activated by Candidalysin in BV-2 microglia to produce IL-295 
1. Candidalysin was previously shown in epithelial cells to activate c-Fos, in a p38-dependent 296 
manner, and the phosphatase MKP-120. We thus asked whether the same pathways are 297 
activated by Candidalysin in BV-2 microglia. We found that Candidalysin sequentially and 298 
dose-dependently activated MKP-1 and c-Fos (Fig. 6e), and chemical inhibition of p38 or c-299 
Fos significantly reduced IL-1 release by Candidalysin-stimulated BV-2 cells (Fig. 6f). 300 
Therefore, microglia produce IL-1 in response to Candidalysin via activation of p38 and c-301 
Fos. 302 
 303 
The Microglia IL-1–CXCL1 Response Requires CARD9 304 
CARD9-deficiency is the only known risk factor that uniquely predisposes to CNS candidiasis 305 
in the absence of iatrogenic intervention2, 5. We first examined whether CARD9-deficiency 306 
causes developmental defects in resident microglia, but found no defects in abundance or 307 
activation markers at steady state in Card9–/– microglia, which accumulated in similar numbers 308 
as wild-type microglia after fungal infection (Supplementary Fig. 5). Since C. albicans 309 
activates the microglial IL-1–CXCL1 axis to regulate protective neutrophil CNS recruitment, 310 
we next analyzed the dependence on CARD9 for induction of this pathway in microglia post-311 
infection in vivo. We hypothesized that CARD9 is required for these functions, as microglia 312 
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highly express CARD9 and we previously found reduced transcription of CXC chemokines by 313 
Card9–/– microglia harvested from the C. albicans-infected brain5. We infected Card9+/+ and 314 
Card9–/– animals with wild-type Candidalysin-expressing C. albicans, isolated phagocytes from 315 
the brain and measured pro-IL-1 and CXCL1 production following ex vivo restimulation. We 316 
found significantly decreased frequencies of CXCL1+ and pro-IL-1+ cells in the fungal-infected 317 
Card9–/– brain, and these decreases mapped to microglia (Fig. 7a,b).  318 
 319 
Since production and secretion of mature IL-1 depends on pro-IL-1 expression and 320 
consecutive inflammasome-dependent processing, we asked whether microglia depend on 321 
CARD9 for pro-IL-1 transcription and/or inflammasome activation. We FACS-sorted microglia 322 
from wild-type and Card9–/– infected brains, and examined Il1b transcription by qRT-PCR, and 323 
levels of pro-IL-1 and cleaved and pro-caspase-1 by immunoblot. We found significantly 324 
decreased Il1b transcription in Card9–/– microglia, which we confirmed at the protein level (Fig. 325 
7c,d). These data are in line with the reported CARD9-dependent pro-IL-1 transcription in 326 
bone marrow-derived dendritic cells post-viral infection29. We also found significantly reduced 327 
cleaved caspase-1 in Card9–/– microglia (Fig. 7d), indicating that Card9 also operates at the 328 
level of inflammasome activation for IL-1 production. Given that c-Fos mediated 329 
Candidalysin-induced IL-1 production by BV-2 cells (Fig. 6e,f), we measured c-Fos 330 
expression in WT and Card9–/– microglia by immunoblot and found significantly decreased c-331 
Fos expression in Card9–/– microglia (Fig. 7d). 332 
 333 
We next examined the NLRP3 inflammasome in FACS-sorted WT and Card9–/– microglia. We 334 
focused on NLRP3 because CARD9 was reported to negatively regulate NLRP3 activation 335 
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during macrophage Salmonella infection30, and we recently showed that Candidalysin 336 
activates NLRP3 in bone marrow-derived macrophages31. We found significantly decreased 337 
NLRP3 protein expression in Card9–/– microglia (Fig. 7e). Of interest, Nlrp3-/- animals had 338 
significantly decreased neutrophil accumulation to the C. albicans-infected brain and increased 339 
fungal load post-infection, consistent with a potential role of Card9-dependent NLRP3-340 
inflammasome activation for protective neutrophil influx in the fungal-infected CNS (Fig. 7f). 341 
Together, microglia require CARD9 for c-Fos activation and for production of mature IL-1 via 342 
Il1b transcriptional regulation and inflammasome activation, to activate the IL-1–CXCL1 axis 343 
in response to fungal invasion. 344 
 345 
Microglial CARD9 Deletion Causes CNS Fungal Invasion 346 
We next directly examined the impact of genetic Card9 deletion specifically within microglia by 347 
utilizing mice expressing tamoxifen-inducible Cre recombinase under the Cx3cr1 promoter 348 
(Cx3cr1CreER)32. These mice has been used to genetically manipulate long-lived CX3CR1+ 349 
microglia while leaving short-lived CX3CR1+ monocytes and monocyte-derived macrophages 350 
unaffected. We bred Cx3cr1CreER animals to Card9-floxed mice11, tamoxifen-pulsed the 351 
progeny to activate Cre expression and waited 4-6 weeks to allow replenishment of short-lived 352 
non-microglia CX3CR1+ cells from the bone marrow, while long-lived microglia remained 353 
Card9-deficient (Supplementary Fig. S6). C. albicans infection of Card9fl/flCx3cr1CreER+/– 354 
animals revealed a significant dependence on Card9 expression by the long-lived CX3CR1+ 355 
cellular compartment for control of fungal brain growth (Fig. 8a), while fungal control in the 356 
kidney was unaffected in microglia-specific conditional Card9–/– mice (Fig. 8a).  357 
 358 
 18 
To analyze whether the susceptibility to brain infection in Card9fl/flCx3cr1CreER+/– mice was 359 
related to a neutrophil recruitment defect, we quantified neutrophils within the infected brains of 360 
Card9fl/flCx3cr1CreER+/– mice and their Cre-negative littermates. We found that microglial 361 
deletion of Card9 significantly reduced the protective early influx of neutrophils into the fungal-362 
infected brain (Fig. 8b), which correlated with significantly decreased expression of microglial 363 
pro-IL1 and CXCL1 in the conditional Card9–/– mice (Fig. 8c). Together, our data shows that 364 
CARD9-expressing microglia orchestrate control of fungal brain invasion, in part by responding 365 
to fungus-secreted Candidalysin, to produce IL-1-induced CXCL1, which recruits CXCR2-366 
expressing neutrophils that are required for CNS fungal clearance (Supplementary Fig. S7).  367 
 19 
Discussion 368 
 369 
Herein, we demonstrate the critical contribution of CARD9-mediated IL-1 and CXCL1 in 370 
recruiting protective neutrophils to the fungal-infected CNS. We identify microglia as major 371 
producers of CARD9-dependent IL-1 and CXCL1 during C. albicans CNS invasion and the 372 
fungal-secreted toxin Candidalysin as a critical pathogen-derived factor activating this 373 
pathway. Our study offers novel insights into the network of host and fungal factors that protect 374 
against CNS fungal invasion and unveil the mechanism of CNS fungal susceptibility in 375 
inherited CARD9-deficiency. 376 
 377 
Systemic candidiasis is a leading cause of nosocomial bloodstream infection with mortality 378 
>50% despite therapy33. Neutropenia is the major predisposing factor for systemic candidiasis 379 
and Candida CNS invasion in particular5, 34. Moreover, CNS invasion is prevalent during 380 
systemic candidiasis in low-birth weight neonates and also occurs as an iatrogenic 381 
complication post-neurosurgical procedures35, 36. Strikingly, CARD9-deficiency is a primary 382 
immunodeficiency disorder (PID) characterized by heightened susceptibility to fungal infections 383 
of which CNS candidiasis is a hallmark2, 3. CARD9-deficiency is the only known PID that 384 
causes fungal-specific infection susceptibility without other infectious or non-infectious 385 
manifestations, and the only PID that causes fungal disease in which CNS is a primary target 386 
tissue17. We previously demonstrated that Candida CNS disease in CARD9-deficiency is 387 
caused by a fungal- and brain-specific defect in neutrophil recruitment5. CNS neutropenia is 388 
now confirmed in several CARD9-deficient patients with CNS candidiasis7, 37, 38. Nonetheless, 389 
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how CARD9 mediates protective neutrophil trafficking into the fungal-infected CNS remained 390 
unclear.  391 
 392 
Our analysis of mice deficient in several CLR, cytokine and chemokine circuits uncovered a) 393 
the functional redundancy among CLRs, which may suggest the presence of yet-undiscovered 394 
CARD9-coupled receptors for tissue-specific protection against fungal invasion; b) the 395 
indispensable role of the CARD9 partner MALT1 in controlling CNS fungal invasion 396 
independent of neutrophil recruitment, which implies that MALT1–/– patients may be at risk for 397 
CNS fungal disease; and c) the critical contribution of IL-1–CXCL1-mediated neutrophil 398 
recruitment for control of CNS fungal invasion. CXCR2 was known to mediate neutrophil 399 
trafficking during viral infection, parasitic meningitis39 and fungal pneumonia40, and herein we 400 
reveal its importance for recruiting neutrophils during C. albicans CNS infection, principally 401 
through binding CXCL1. In contrast, CCR1, CXCR1 and LTB4R1 are dispensable despite 402 
them regulating neutrophil recruitment and function in other C. albicans-infected tissues13, 14, 15. 403 
These studies further underscore the organ- and context-specific dependence on chemotactic 404 
molecules for protective host immunity.  405 
 406 
We showed that IL-1 is required for CXCL1 induction, in line with earlier work which showed 407 
IL-1induced CXCL1 production controlling neutrophil accumulation during bacterial 408 
peritonitis and autoimmune, traumatic or bacterial neuroinflammation10, 41, 42. Importantly, 409 
microglia are the primary myeloid cellular source of IL-1-dependent CXCL1 production in 410 
vivo. During oral candidiasis, IL-1R is also required for neutrophil accumulation to the oral 411 
mucosa8, as we have shown for systemic infection in the brain. However, further attesting to 412 
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the presence of tissue-specific anti-Candida immune response cues, the IL-1R-dependent 413 
response in the oral epithelium is largely controlled by IL-1 released by damaged 414 
keratinocytes8, whereas we found that IL-1 plays a modest role in the control of brain fungal 415 
invasion. In fact, IL-1 release by epithelial cells, in both the oral and vaginal mucosal barriers, 416 
is driven by exposure to the fungal secreted toxin Candidalysin19, 20, 21.   417 
 418 
Candidalysin enables the establishment of C. albicans mucosal infections, since Candidalysin-419 
deficient strains are avirulent in these models19, 21. In contrast, we found that Candidalysin-420 
deficient strains are hyper-virulent for the brain, associated with decreased IL-1 and CXCL1 421 
production and impaired neutrophil recruitment. These results indicate that Candidalysin is not 422 
only a classical virulence factor, but also an immune modulator, which exerts context-specific 423 
effects on the immune system. We propose that this dual function of Candidalysin is the result 424 
of a co-evolutionary event; the fungus developed an efficient toxin to damage host 425 
membranes, and, in response, the host evolved a sensitive Candidalysin detection system to 426 
defend against this common mucosal pathogen. Whether Candidalysin is recognized by a 427 
specific microglial innate receptor to mediate the protective IL-1–CXCL1 axis is unclear, since 428 
the toxin mediates cellular damage which could also activate glial cells. Therefore, identifying 429 
how host epithelial and immune cells recognize Candidalysin merits investigation. 430 
 431 
We found that Candidalysin selectively activates microglia for IL-1 and CXCL1 production, a 432 
self-renewing macrophage population that contributes towards neuroinflammation in 433 
neurodegenerative disorders and promotes pathogen and dead cell clearance within the 434 
CNS43. Interestingly, downstream of Candidalysin-induced microglial IL-1 secretion, which 435 
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occurs via c-Fos activation, we show that additional signals derived from astrocytes acting in 436 
trans are required for microglia to secrete CXCL1. Whether direct microglia-astrocyte contact 437 
is required or astrocyte-derived soluble factors acting on microglia are needed remains 438 
unknown. Indeed, microglia are known to interact with astrocytes to drive or suppress 439 
inflammation44, 45. Therefore, the molecular factors that drive microglia-astrocyte cross-talk 440 
within the fungal-infected brain warrant further investigation.  441 
 442 
Lastly, we examined the dependence on CARD9 for the microglia-mediated, IL-1CXCL1-443 
dependent pathway that recruits protective neutrophils, using fully Card9-deficient and 444 
conditional microglia-specific Card9–/– mice. We show that CARD9 is critical for c-Fos 445 
activation and for the production of both IL-1 and CXCL1 by microglia in the infected CNS 446 
operating at the levels of both transcriptional pro-IL-1 regulation and inflammasome activation 447 
for IL-1 generation, with NLRP3 being at least partly involved, as shown with Microsporum 448 
infection46. Together, these data shed light into the pathogenesis of inherited CARD9-449 
deficiency by outlining a pathway of CARD9-dependent microglial production of sequential IL-450 
1 and CXCL1 that recruits protective neutrophils into the fungal-infected CNS.  451 
 452 
Future studies should examine how Card9 promotes microglial innate functions beyond 453 
orchestrating neutrophil recruitment such as fungal uptake and killing. Of note, the phenotype 454 
of the microglia-specific conditional knockout mice is less severe than that of Card9–/– mice, 455 
which may reflect the important role of astrocytes, which express Card9 post-Candida 456 
infection13, in priming microglial CXCL1 production. Future work should also examine the 457 
potentially differential tissue-specific dependence on Card9 for neutrophil recruitment by non-458 
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CNS tissue-resident macrophages, such as Kupffer cells, as previously shown for 459 
macrophages and dendritic cells47, which will help further understand the CNS-specificity of 460 
fungal disease in CARD9-deficiency. Beyond understanding the pathogenesis of inherited 461 
CARD9-deficiency, our findings have important implications for recognizing the potential fungal 462 
infection risk in patients who are increasingly receiving Syk inhibitors for the treatment of 463 
autoimmune and malignant diseases48, 49. Surveillance of Syk inhibitor-treated patients and 464 
research in conditional Syk-deficient mice will help determine their CNS fungal disease risk. 465 
 466 
In summary, we present evidence of an intricate host immune pathway that protects the CNS 467 
from invading fungi. This work uncovers the complex interactions occurring between the host 468 
and the most common human fungal pathogen within the CNS, and sheds novel mechanistic 469 
light into the pathogenesis of inherited CARD9-deficiency.  470 
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Methods 681 
 682 
Mice 683 
Animals (males and females) were used at 8-12 weeks of age and were maintained in 684 
individually ventilated cages under specific pathogen-free conditions at the 14BS facility at the 685 
National Institutes of Health (Bethesda, MD, USA), the Memorial Sloan Kettering Cancer 686 
Center Comparative Medicine Shared Resources (New York, NY, USA), or the Medical 687 
Research Facility at the University of Aberdeen (UK). The following strains (and their 688 
respective WT controls/littermates) were obtained from the NIAID Taconic contract; Cxcr2–/–, 689 
Il1r–/–, Ltb4r1–/–, Fpr1–/–. All other strains and their respective controls/littermates were bred in-690 
house at the NIH (Clec7a–/–, Clec4n–/–, Clec4e–/–, Myd88–/–, Ccr1–/–, Cxcr1–/–, Cxcl1–/–, Il1a–/–, 691 
Il1b–/–, Il1a–/–Il1b–/–, Nlrp3–/–, Card9fl/flCx3CR1CreER+/–), Memorial Sloan-Kettering Cancer Center 692 
(Clec7a–/–Fcer1g–/–), University of Aberdeen (Clec4d–/–), or USUHS (Malt1–/–)51. Mice 693 
homozygous for the Card9tm1a allele were purchased from the Wellcome Trust Sanger Institute 694 
(EUCOMM Project No. 44813), and these animals were bred with the FLPer deleter strain 695 
(Jackson Laboratories) to remove the FRT-flanked knock-out first cassette, generating 696 
Card9tm1c homozygous mice (referred to as Card9fl/fl in this manuscript)52,53. Homozygous 697 
Card9fl/fl animals were bred with heterozygous Cx3cr1CreER transgenic animals (Jackson 698 
Laboratories) to generate Card9fl/flCx3cr1CreER+/- mice and littermate controls. Soon after 699 
weaning (~5-6 weeks old), Card9fl/flCx3cr1CreER+/- mice and their controls were treated with two 700 
10mg doses of tamoxifen (Sigma) administered in corn oil by oral gavage, given 48 h apart. 701 
After 4-6 weeks, these animals were infected and analyzed as outlined in the Figure legends. 702 
 31 
All experimentation conformed to conditions approved by the Animal Care and Use Committee 703 
of the National Institute of Allergy and Infectious Diseases.  704 
 705 
Candidiasis Model and Fungal Burden Determination 706 
Candida albicans strains used in this study were SC5314, BWP17, ece1∆/∆, ece1∆/∆+ECE1, 707 
ece1∆/∆+ECE1∆184-279 19, CAI4+CIp10 and sap4/5/6∆/∆, and hgc1∆/∆ and hgc1∆/∆ + HGC118. 708 
Yeast was serially passaged three times in YPD broth, grown at 30°C with shaking for 18-24 h 709 
at each passage. Yeast cells were washed in PBS, counted, and injected intravenously via the 710 
lateral tail vein. Animals were infected with 1.3 × 105 colony forming units (CFU) for analysis at 711 
24 h post-infection, or 7 × 104 CFU for analysis at 72 h post-infection, unless otherwise stated 712 
in the corresponding Figure legends. For analysis of brain fungal burdens, animals were 713 
euthanized and brains weighed, homogenized in PBS, and serially diluted before plating onto 714 
YPD agar supplemented with Penicillin/Streptomycin (Invitrogen). Colonies were counted after 715 
incubation at 37°C for 24-48 h. 716 
 717 
Analysis of Brain Neutrophil Recruitment by FACS 718 
Leukocytes were isolated from brains using previously described methods54, resuspended in 719 
PBS and stained with Live/Dead fluorescent dye (Invitrogen) for 10 min on ice. Cells were then 720 
stained with fluorophore-conjugated antibodies in the presence of anti-CD16/32 and 0.5% BSA 721 
for 30 min on ice. Samples were washed in PBS/0.5% BSA/0.01% sodium azide and acquired 722 
using the BD Fortessa instrument equipped with BD FACS Diva software (BD Biosciences). 723 
FlowJo (TreeStar) was used for the final analysis. Anti-mouse antibodies used in this study 724 
 32 
were: CD45 (30-F11), CD11b (M1/70), both from eBiosciences, and Ly6G (1A8), Ly6C (AL-725 
21), both from BD Biosciences. 726 
 727 
Histology 728 
Brains were removed from infected mice at the indicated time points and fixed in 10% formalin 729 
for 24 h before embedding in paraffin wax. Tissue sections were stained with periodic acid-730 
Schiff (PAS). 731 
 732 
Measurement of Cytokines and Chemokines in Brain Homogenates 733 
Infected brains were isolated at 24 h post-infection and homogenized in 1 mL PBS 734 
supplemented with 0.05% Tween20 and protease inhibitor cocktail (Roche). Homogenized 735 
brains were centrifuged twice to remove debris and resulting supernatants snap-frozen on dry 736 
ice and stored at –80 C prior to analysis. IL-1 and CXCL1 concentrations in the 737 
homogenates was determined by ELISA (R&D Systems), following the manufacturers’ 738 
instructions. 739 
 740 
Ex Vivo Restimulations and Intracellular FACS Analysis 741 
Animals were infected with 2 × 105 CFU of the indicated C. albicans strains intravenously, and 742 
brain leukocytes isolated 24 h later. For these experiments, brains were first digested in RPMI 743 
supplemented with 0.8 mg/mL Dispase (Gibco), 0.2mg/mL Collagenase Type 4 (Worthington), 744 
and 0.1 mg/mL DNAse (Roche) at 37 C for 30 min, then pipetted vigorously to create a 745 
homogenous suspension. These suspensions were centrifuged (1500 rpm, 5 min, 4 C), 746 
pellets resuspended in 5 mL 40% Percoll (GE Healthcare) and centrifuged again at 1700 rpm 747 
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for 20 min at 4 C to remove myelin. Cell pellets were washed in RPMI supplemented with 748 
10% heat-inactivated fetal bovine serum and Penicillin/Streptomycin (Invitrogen), and added to 749 
FACS tubes for stimulations. Cells were incubated for 4 h at 37 C in the presence of 5 g/mL 750 
Brefeldin A (Sigma) and, where indicated, 1 g/mL LPS (Sigma) or 62.5 g/mL depleted 751 
zymosan (Sigma). After stimulation, cells were washed in PBS and stained for surface markers 752 
as above. Fixation/permeabilization was performed with the eBioscience Foxp3 staining kit, 753 
and staining for CXCL1 (IC4532R, from R&D Systems) or pro-IL-1 (NJTEN3; from 754 
eBioscience) performed overnight at 4 C. Samples were washed once in PBS/0.5% 755 
BSA/0.01% sodium azide prior to acquisition using the BD Fortessa instrument equipped with 756 
BD FACS Diva software (BD Biosciences). FlowJo (TreeStar) was used for the final analysis. 757 
CXCL1+ and pro-IL-1+ cells were determined by employing similar staining and gating in 758 
animals deficient in these mediators (Cxcl1–/–, Il1b–/–) as negative controls. 759 
 760 
Cell Culture and Candidalysin Stimulations 761 
BV-2 cells were kindly provided by F. Crews (University of North Carolina School of Medicine). 762 
C8-D1A astrocytes were kindly provided by D. McGavern (NINDS, NIH). BV-2 were 763 
maintained at 37 C, 5% CO2 in RPMI supplemented with L-glutamine and HEPES (pH 7.0 – 764 
7.4; Corning), 10% heat-inactivated fetal bovine serum and Penicillin/Streptomycin 765 
(Invitrogen). DMEM media was used as the base media for C8-D1A culture, with the same 766 
supplements as listed above and cultured as for BV-2. For BV-2 single culture experiments, 767 
cells were lifted using cell scrapers and seeded into 24 well-plates at 5 × 105 cells/well (BV-2) 768 
and left to adhere for 2 h at 37C with either: 50 ng/mL LPS (Sigma), T-5224 (APExBIO) 769 
and/or SB203580 (Adipogen); see Figure legends for details of each experiment. After 2 h, 770 
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recombinant Candidalysin peptide (Peptide Protein Research) was added to the cells at the 771 
indicated concentrations and incubation at 37 C continued. For co-culture experiments, 3 × 772 
105 C8-D1A were added to each well of a 24 well-plate and incubated overnight at 37 °C. BV-2 773 
cells and Candidalysin were added as described above. In both types of experiments, 774 
supernatants or cells were collected at the indicated time points after Candidalysin addition 775 
and analyzed for IL-1 and CXCL1 by ELISA (R&D Systems), CXCL1 staining by intracellular 776 
flow cytometry, or by immunoblot. 777 
 778 
Immunoblot Analysis 779 
Whole cell lysates were suspended in RIPA buffer containing protease and phosphatase 780 
inhibitors (Thermo Scientific). Lysates were separated in SDS-PAGE and transferred to a 781 
nitrocellulose membrane, 0.2 m (Bio-Rad Laboratories). The membrane was incubated with 782 
the following primary antibodies: phospho-MPK1/MPK2 polyclonal [Ser296, Ser318] (Thermo 783 
Scientific) and c-Fos (Cell Signaling), IL-1 [3A6] (Cell Signaling), Caspase-1 p20 [Casper-1] 784 
(Adipogen Life Sciences) (Thermo Scientific), NLRP3 [D4D8T] (Cell Signaling). Normalization 785 
was performed by probing the membrane with -Actin antibody (Cell Signaling). 786 
Chemiluminescence detection was performed with ClarityTM Western ECL Substrate (Bio-Rad 787 
Laboratories), using the ChemiDocTM MP Imaging System (Bio-Rad). 788 
 789 
FACS/MACS Sorting of Microglia 790 
Wild-type animals were infected with 1.3 × 105 CFU SC5314 and euthanized at 24 h post-791 
infection. Brains were digested as above and leukocytes stained with sterile antibodies55. 792 
Ly6Chi monocytes (CD45hi CD11b+ Ly6Chi Ly6G–) and microglia (CD45lo CD11b+ Ly6G– Ly6C–) 793 
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were FACS-sorted into sterile sorting buffer (HBSS supplemented with 2 mM EDTA, 10 % 794 
FCS, 100 U/mL penicillin, 100 g/mL streptomycin) using a FACS Aria instrument for 795 
downstream qRT-PCR and immunoblot analyses. Purity of cells were greater than >95%, on 796 
average. In some experiments (qRT-PCR of CLRs in brain-resident microglia; Supplementary 797 
Fig. 1), microglia were instead sorted by magnetic separation using anti-CD11b microbeads 798 
(Miltenyi). Cells were then centrifuged (1500 rpm 5 min, 4 °C) and resuspended in Trizol for 799 
RNA purification or RIPA buffer for downstream immunoblot analysis. Depending on the 800 
experiment, up to 5 animals were pooled for individual sorts, or individual mice were analyzed 801 
separately (see Figure legends for details). 802 
 803 
Generation of cDNA and qRT-PCR 804 
RNA was extracted from sorted brain myeloid cells (defined using the gating strategy shown in 805 
Supplementary Fig. 2) using Trizol (Invitrogen) and the RNeasy kit (Qiagen) per the 806 
manufacturer’s protocol. Purified RNA was used as a template for cDNA generation using the 807 
qScript cDNA SuperMix kit (Quanta Biosciences) with oligodT and random primers. 808 
Quantitative PCR was performed by TaqMan detection (PerfeCTa qPCR FastMix ROX; 809 
Quanta BioSciences) with the 7900HT Fast Real-Time PCR System (Applied Biosystems). All 810 
qPCR assays were performed in duplicate and the relative gene expression of each gene was 811 
determined after normalization with GAPDH transcript levels using the CT method. TaqMan 812 
primers/probes (Clec7a, Clec4n, Clec4d, Clec4e, Il1b, Card9, Gapdh) were predesigned by 813 
Applied Biosystems. 814 
 815 
Statistics 816 
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Statistical analyses were performed using GraphPad Prism 7.0 software. Details of individual 817 
tests are included in the figure legends. In general, data was tested for normal distribution by 818 
Kolmogorov-Smirnov normality test and analyzed accordingly by unpaired t-tests or Mann 819 
Whitney U-test. In cases where multiple data sets were analyzed, two-way ANOVA was used 820 
with Bonferroni correction. In all cases, P values <0.05 were considered significant. 821 
 822 
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Figure Legends 843 
 844 
Fig. 1: CARD9-coupled C-type lectin receptors functionally compensate for one another 845 
for protective neutrophil recruitment to the fungal-infected brain. a, Card9–/– mice (n=4 846 
animals) and their wild-type controls (n=4 animals) were intravenously infected with C. albicans 847 
SC5314 and analyzed for neutrophil counts by flow cytometry at 24 h post-infection (left; dose: 848 
1.3 × 105 CFU) and fungal growth within the brain at 72 h post-infection (right; dose: 7 × 104 849 
CFU). b, Animals of the indicated genotype (WT n = 9 animals, Clec7a–/– n = 6 animals; WT n 850 
= 12 animals, Clec4n–/– n = 10 animals; WT n = 6 animals, Clec4d–/– n = 6 animals; WT n = 6 851 
animals, Clec4e–/– n = 8 animals; WT n = 10 animals, Clec7a–/–Fcer1g–/– n = 9 animals) were 852 
intravenously infected with C. albicans SC5314 (2 × 105 CFU for Clec4d–/– and Clec7a–/–853 
Fcer1g–/– and their controls; 1.3 × 105 all others) and analyzed for neutrophil counts by flow 854 
cytometry at 24 h post-infection and c, fungal burdens in the brain at 24 and 72 h post-infection 855 
(WT n = 9 animals, Clec7a–/– n = 6 animals; WT n = 10 animals, Clec4n–/– n = 10 animals; WT 856 
n = 10 animals, Clec4d–/– n = 10 animals; WT n = 6 animals, Clec4e–/– n = 4 animals; WT n = 857 
10 animals, Clec7a–/–Fcer1g–/– n = 9 animals). d, Malt1–/– mice and their littermate controls were 858 
infected as above and analyzed for fungal burdens in the brain (right; WT n = 7 animals, Malt1–859 
/– n = 5 animals) and neutrophil recruitment to the brain at 24 h post-infection (left; WT n = 5 860 
animals, Malt1–/– n = 5 animals). In all cases, ‘wild type’ refers to appropriate matched control 861 
animals for each knock-out line for gender, age and genetic background. Individual points 862 
represent different mice. Data is pooled from 2 independent experiments and is shown as 863 
mean +/- SEM, and analyzed by unpaired two-tailed t-test (panel a [left], b) or two-tailed Mann 864 
Whitney U-test (panel a [right], c, d). *P<0.05, **P<0.01, ***P<0.005, ****P<0.001. 865 
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 866 
Fig. 2: IL-1 and CXCL1 are critical for protective neutrophil recruitment to the fungal-867 
infected brain. a,b, Animals deficient in elements of the IL-1R signaling pathway or c,d, 868 
chemokine receptors and their ligands, were infected and analyzed for neutrophil recruitment 869 
at 24 h post-infection (a,c) and control of fungal brain infection (b,d) as in Fig. 1. ‘Wild type’ 870 
refers to appropriate matched control animals for each knock-out line for gender, age and 871 
genetic background. Individual points represent different mice; (a) WT n = 8 animals, Il1r–/– n = 872 
8 animals; WT n = 7 animals, Myd88–/– n = 6 animals; WT n = 12 animals, Il1a–/– n = 12 873 
animals; WT n = 6 animals, Il1b–/– n = 6 animals; WT n = 8 animals, Il1a–/–Il1b–/– n = 6 animals. 874 
(b) WT n = 8 animals, Il1r–/– n = 7 animals; WT n = 7 animals, Myd88–/– n = 6 animals; WT n = 875 
3-8 animals, Il1a–/– n = 4-8 animals; WT n = 6 animals, Il1b–/– n = 6 animals; WT n = 6 animals, 876 
Il1a–/–Il1b–/– n = 6 animals. (c) WT n = 6 animals, Ccr1–/– n = 6 animals; WT n = 11 animals, 877 
Cxcr1–/– n = 11 animals; WT n = 14 animals, Cxcr2–/– n = 16 animals; WT n = 8 animals, Cxcl1–878 
/– n = 7 animals. (d) WT n = 6-7 animals, Ccr1–/– n = 6-7 animals; WT n = 7-10 animals, Cxcr1–/– 879 
n = 7-10 animals; WT n = 8-10 animals, Cxcr2–/– n = 7-10 animals; WT n = 6-8 animals, Cxcl1–880 
/– n = 5-7 animals. Data is pooled from 2-3 independent experiments and shown as mean +/- 881 
SEM, analyzed by unpaired two-tailed t-test (panel a, c) or two-tailed Mann Whitney U-test 882 
(panel b, d). *P<0.05, **P<0.01, ***P<0.005, ****P<0.001. 883 
 884 
Fig. 3: Production of CXCL1 is dependent on IL-1in the fungal-infected brain. a, Wild 885 
type (n = 6/7 animals), Cxcl1–/– (n = 5 animals) and Il1b–/– (n = 6 animals) animals were infected 886 
as in Fig. 1 and brains isolated at 24 h post-infection and analyzed for CXCL1 or IL-1 887 
production by ELISA. Data is pooled from 2 independent experiments and analyzed by 888 
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unpaired two-tailed t-test. b, The relative proportions of myeloid cell populations (gated within 889 
live CD45+ singlets) in the uninfected ( n = 6 animals) and 24 h infected WT (n = 6 animals) 890 
brain (left), and the relative proportion of myeloid cell populations producing CXCL1  (n = 3 891 
animals) or pro-IL-1 (n = 9 animals) in the 24 h infected brain (right). For the latter, total 892 
CD45+CXCL1(or IL-1)+ cells were first gated and then cell types defined within this initial gate 893 
using lineage markers (see below), using samples from the unstimulated condition. Data is 894 
shown as the mean +/- SEM. c, Wild type (n = 3 animals) and Il1b–/– mice (n = 4 animals) were 895 
infected with 2 × 105 C. albicans and brain cells analyzed for CXCL1 production by intracellular 896 
flow cytometry 24 h later. Brain cells were restimulated ex vivo with 62.5 µg/mL depleted 897 
zymosan or 1 µg/mL LPS for 4 h in the presence of 5 µg/mL Brefeldin A. Representative plots 898 
from the LPS-stimulated condition are gated on microglia (top; CD45int Ly6G– CD11b+), Ly6Chi 899 
monocytes (middle; CD45hi Ly6Chi Ly6G– CD11b+) and neutrophils (bottom; CD45hi Ly6Cint 900 
Ly6Ghi CD11b+), showing corresponding Cxcl1–/– cells as gating controls. In all panels, ‘wild 901 
type’ refers to appropriate matched control animals for each knock-out line for gender, age and 902 
genetic background. Individual points represent different mice. Data shown as mean +/- SEM, 903 
and analyzed by unpaired two-tailed t-test. *P<0.05, **P<0.01. 904 
 905 
Fig. 4: Candidalysin is a specific hyphal-secreted factor promoting neutrophil 906 
recruitment and control of fungal growth in the brain. a,b,c,e, Animals were infected with 2 907 
× 105 CFU of the indicated C. albicans strains (parental strains, closed symbols; deficient 908 
mutants, open symbols) and analyzed as in Fig. 1 for fungal burdens (hgc1∆/∆ n = 8 animals, 909 
hgc1∆/∆ + HGC1 n = 7 animals; BWP17 n = 10 animals, ece1∆/∆ n = 11 animals, ece1∆/∆ + 910 
ECE1 n = 10 animals, ece1∆/∆ + ECE1∆184-279  n = 11 animals; CAI4 + CIp10 n = 6 animals, 911 
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sap4/5/6∆/∆ + CIp10 n = 6 animals) and neutrophil recruitment (hgc1∆/∆ n = 10 animals, 912 
hgc1∆/∆ + HGC1 n = 10 animals; BWP17 n = 7 animals, ece1∆/∆ n = 7 animals, ece1∆/∆ + 913 
ECE1 n = 7 animals, ece1∆/∆ + ECE1∆184-279  n = 11 animals; CAI4 + CIp10 n = 6 animals, 914 
sap4/5/6∆/∆ + CIp10 n = 7 animals). Histology shown in (c) is from 24 h post-infection, stained 915 
with PAS. Scale bar is 50 µm. d, Whole brain homogenates from animals infected with 916 
indicated strains were isolated at 24 h post-infection and analyzed for IL-1 and CXCL1 using 917 
ELISA (BWP17 n = 8-10 animals, ece1∆/∆ n = 8-10 animals, ece1∆/∆ + ECE1 n = 6-11 918 
animals, ece1∆/∆ + ECE1∆184-279  n = 7-11 animals).  Individual points represent different mice. 919 
Data is pooled from 2-4 independent experiments and shown as mean +/- SEM, analyzed by 920 
unpaired two-tailed t-test, or two-tailed Mann Whitney U-test (panel a, left). *P<0.05, **P<0.01, 921 
***P<0.005; ns = not significant. 922 
 923 
Fig. 5: Microglia produce IL-1β and CXCL1 in a Candidalysin-dependent manner.  924 
Animals were infected with wild-type C. albicans (BWP17; closed bars) or a Candidalysin-null 925 
strain (ece1∆/∆; open bars), and brain cells isolated 24 h later. Brain leukocytes were 926 
restimulated as in Fig. 3, and intracellular staining for a, IL-1β (unstimulated, n = 8 animals; 927 
zymosan, n = 4 animals; LPS n = 6 animals) and b, CXCL1 (unstimulated, n = 12 animals; 928 
zymosan, n = 6 animals; LPS n = 9 animals) was analyzed by flow cytometry. Box-and-whisker 929 
plots show the minimum/maximum values (whiskers), the 25th/75th percentiles and the median. 930 
Data is pooled from 2-4 independent experiments and analyzed by unpaired two-tailed t-tests. 931 
*P<0.05, **P<0.01. Representative staining is shown for LPS-stimulated microglia (gated as in 932 
Fig. 3) from wild-type mice infected with indicated strains, or BWP17-infected cytokine-933 
deficient mutants as control.  934 
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 935 
Fig. 6: Candidalysin activates IL-1β production from microglia via p38-cFos signaling 936 
and promotes CXCL1 production from microglia through interactions with astrocytes. 937 
BV-2 microglia were seeded into 24-well plates at 5 × 105 per well and left to adhere for 2 h in 938 
the presence of 50 n g/mL LPS (for priming) before the addition of purified Candidalysin at the 939 
indicated concentrations. Cell culture supernatants were analyzed for a, IL-1 production or b, 940 
LDH release after 24 h of stimulation. Data is shown with the mean +/- SEM, individual points 941 
represent individual culture wells (n = 4). c-d, In some experiments, BV-2 cells were co-942 
cultured with 3 × 105 C8-D1A astrocytes, and CXCL1 production analyzed in the supernatant 943 
by ELISA (n = 10 individual culture wells) or by intracellular flow cytometry (n = 3-5 individual 944 
culture wells; data shown with the mean). In d, microglia and astrocytes were distinguished by 945 
CD45 staining, and CXCL1 production assessed within CD45+ (microglia) and CD45- 946 
(astrocyte) gates. Histogram is gated on CD45+ microglia. e, To measure cFos and pMKP1/2 947 
activation, BV-2 cells were stimulated with the indicated Candidalysin concentrations for 30 or 948 
120 min and BV-2 cells then lysed and analyzed for cFos and pMKP1/2 by immunoblot, 949 
normalizing to -actin. Immunoblots shown are representative of 2 independent experiments. f, 950 
BV-2 cells were cultured in the presence of the indicated cFos and p38 inhibitors for 2 h prior 951 
to stimulating with 20 µM Candidalysin, and IL-1 measured in the supernatant by ELISA after 952 
24 h (data shown as mean +/- SEM; n = 6 individual culture wells). All data is pooled from 2 953 
independent experiments and analyzed by one-way ANOVA. *P<0.05, **P<0.01, ***P<0.005, 954 
****P<0.0001. 955 
 956 
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Fig. 7: CARD9 is required for the production of IL-1 via regulation of pro-IL-1 957 
transcription and inflammasome activation, and of CXCL1 in the fungal-infected brain.  958 
a,b, Card9+/+ ( n = 13 animals) and Card9–/– (n = 13 animals) animals were infected with 2 × 959 
105 CFU wild-type C. albicans (BWP17), and brain cells isolated 24 h later. Brain leukocytes 960 
were restimulated as in Fig. 4, and intracellular staining for pro-IL-1β and CXCL1 analyzed by 961 
flow cytometry in total CD45+ cells (LPS-stimulated condition shown) (a) or microglia alone, 962 
normalized to Card9+/+ results (b). Panels a,b show pooled data from 4 independent 963 
experiments, analyzed with two-tailed unpaired t-test. Data shown as mean +/- SEM (a) or with 964 
minimum/maximum values (whiskers), the 25th/75th percentiles and the median (b). c, 965 
Microglia were FACS-sorted from pooled Card9+/+ (n = 4 animals) and Card9–/– animals (n = 4 966 
animals) at 24 h post-infection and analyzed by unpaired two-tailed t-test for Il1b expression by 967 
qRT-PCR, or d,e, the indicated proteins by immunoblot (Caspase and IL-1 blots; WT n = 6 968 
animals, Card9–/– n = 7 animals; cFos blot; WT n = 10 animals, Card9–/– n = 10 animals; NLRP3 969 
blot; WT n = 8 animals, Card9–/– n = 8 animals;). Graphs in (d,e) represent the band pixel 970 
density normalized to the wild type control, and are shown with mean +/- SEM and analyzed by 971 
unpaired two-tailed student t-tests. Example blots are representative of 3 independent FACS 972 
sorts/experiments; pooled data is shown in the graphs above. f, Nlrp3–/– animals and their wild-973 
type controls were infected with 1.3 × 105 CFU C. albicans and analyzed by unpaired two-974 
tailed t-tests for neutrophil recruitment to the brain 24 h later (left; WT n = 9 animals, Nlrp3–/– n 975 
= 8 animals) and by two-tailed Mann-Whitney U-test for fungal brain burdens at 72 h post-976 
infection (right; WT n = 14 animals, Nlrp3–/– n = 14 animals), as described in Fig. 1. *P<0.05, 977 
**P<0.01, ***P<0.005. 978 
 979 
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Fig. 8: CARD9 is required specifically in microglia for neutrophil recruitment and control 980 
of fungal invasion in the CNS. a, Card9fl/flCx3cr1CreER–/– and Card9fl/flCx3cr1CreER+/– littermates 981 
(n=8-13) were tamoxifen-pulsed at 4-5 weeks of age, left to rest for 4-6 weeks and then 982 
infected with 1.3 × 105 CFU C. albicans (SC5314) intravenously and analyzed for brain and 983 
kidney fungal burdens (Card9fl/flCx3cr1CreER–/–  n = 8-10 animals; Card9fl/flCx3cr1CreER+/– n = 8 984 
animals), b, neutrophil recruitment to the brain at 24 h post-infection (Card9fl/flCx3cr1CreER–/– n = 985 
13 animals; Card9fl/flCx3cr1CreER+/– n = 9 animals), and c, intracellular staining for pro-IL-1β and 986 
CXCL1, as described in Fig. 3 (Card9fl/flCx3cr1CreER–/– n = 8 animals; Card9fl/flCx3cr1CreER+/– n = 987 
8 animals). Data is pooled from 2-4 independent experiments and is shown as mean +/- SEM, 988 
analyzed by two-tailed Mann-Whitney U-tests (panel a) or two-tailed unpaired t-tests (panel b, 989 
c). *P<0.05, **P<0.01.  990 
